The number of lawsuits filed by people who say they suffered serious side effects after taking Invokana (canagliflozin) continues to grow in Philadelphia amid rising safety concerns. Attorneys are also investigating other drugs in the Type 2 diabetes drug class known SGLT2 inhibitors.
While attorneys across the country are filing lawsuits on behalf of local plaintiffs, Pennsylvania is seeing a large number of cases. Dozens of cases made their way to Philadelphia. An attorney family with the cases told a reporter at the Legal Intelligencer that more than 150 suits are pending in Missouri and Illinois.
Attorneys say a judge may consolidate the cases if the volume continues to grow.
“With those kinds of numbers, you know it’s going to get to mass tort status and [federal multidistrict litigation] status,” an attorney familiar with multidistrict litigation said.
Lawsuits allege Invokana’s manufacturer failed to warn about serious side effects linked to the drug. These side effects include blood infections caused by urinary tract infection, strokes, diabetic ketoacidosis and kidney failure
Some plaintiffs also filed wrongful death claims.
Ida Mae Jones Jackson’s family filed a lawsuit against Janssen in Louisiana after she took Invokana and suffered ketoacidosis that led to kidney damage, a heart attack and stroke. The complications led to her death. The suit claims the makers of Invokana knew about the risks and withheld information from patients and doctors.
The list of serious side effects linked to Invokana and other SGLT2 drugs, including Farxiga (dapagliflozin) and Jardiance (empagliflozin), continues to grow.
The FDA issued a safety communication in May 2015, and warned that all SGLT2 inhibitors could increase the risk of diabetic ketoacidosis—a serious condition that could lead to coma and even death, if not treated.
If you or a loved took Invokana and developed diabetic ketoacidosis contact our office immediately. Our law office handles Invokana lawsuits from across the country.